Diallyl Disulfide Mitigates LPS-Induced Inhibition of Osteogenic Differentiation and Alleviates Inflammatory Bone Loss via PI3K/AKT Signaling Pathway.
Saved in:
| Title: | Diallyl Disulfide Mitigates LPS-Induced Inhibition of Osteogenic Differentiation and Alleviates Inflammatory Bone Loss via PI3K/AKT Signaling Pathway. |
|---|---|
| Authors: | Wu J; War Trauma Medical Center, State Key Laboratory of Trauma and Chemical Poisoning, Army Medical Center, Daping Hospital, Army Medical University, Chongqing, 400042, People's Republic of China., Guo D; Department of Emergency, Army Medical Center, Daping Hospital, Army Medical University, Chongqing, 400042, People's Republic of China., Du Y; Department of Paediatric Oncology, Haematology, Oncology and Immunology, Heidelberg University, Heidelberg, Germany., Wang Z; Department of Orthopedics, Affiliated Hospital of Southwest Medical University, Luzhou, 646000, People's Republic of China., Li S; War Trauma Medical Center, State Key Laboratory of Trauma and Chemical Poisoning, Army Medical Center, Daping Hospital, Army Medical University, Chongqing, 400042, People's Republic of China., Xu H; War Trauma Medical Center, State Key Laboratory of Trauma and Chemical Poisoning, Army Medical Center, Daping Hospital, Army Medical University, Chongqing, 400042, People's Republic of China., Chu X; War Trauma Medical Center, State Key Laboratory of Trauma and Chemical Poisoning, Army Medical Center, Daping Hospital, Army Medical University, Chongqing, 400042, People's Republic of China., Gao X; Department of Emergency, The People's Hospital of Nan'an District, Chongqing, 400060, People's Republic of China., Li L; Department of Stem Cell and Regenerative Medicine, Army Medical Center, Daping Hospital, Army Medical University, Chongqing, 400042, People's Republic of China., Fei J; War Trauma Medical Center, State Key Laboratory of Trauma and Chemical Poisoning, Army Medical Center, Daping Hospital, Army Medical University, Chongqing, 400042, People's Republic of China. |
| Source: | Drug design, development and therapy [Drug Des Devel Ther] 2026 Apr 14; Vol. 20, pp. 590959. Date of Electronic Publication: 2026 Apr 14 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475745 Publication Model: eCollection Cited Medium: Internet ISSN: 1177-8881 (Electronic) Linking ISSN: 11778881 NLM ISO Abbreviation: Drug Des Devel Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1177-8881 |
|---|---|
| DOI: | 10.2147/DDDT.S590959 |
